Skip to content
Screener

Illumina ILMN Other income, net (Note 6)

Other income, net (Note 6) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$31M
Azenta logo
AzentaAZTA
$1.2M+246%
Personalis, Inc. logo
Personalis, Inc.PSNL
$20K+143%
Guardant Health logo
Guardant HealthGH
-$157K-102%
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$175K+144%
Natera, Inc. logo
Natera, Inc.NTRA
$9.45M-12.0%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Gross profit$770.0M+10.8%
Operating income$245.0M+14.5%
Net income$207.0M-11.9%
EPS (diluted)$1.35-9.4%

Balance sheet

See full
Cash & equivalents$1.0B+11.3%
Total debt$1.9B-7.3%
Total equity$2.8B+25.7%
Total assets$6.7B+9.2%

Cash flow

See full
Operating cash flow$201.0M-14.1%
CapEx$39.0M+30.0%
Free cash flow$162.0M-20.6%

Valuation

See full
Market cap$29.25B+95.7%
Enterprise value$30.16B+87.2%
P/E35.5×+23.6×
P/S6.5×+3.0×

Profitability

See full
Gross margin66.4%-0.2pp
Operating margin19.6%
Net margin18.4%-11.0pp
FCF margin20.7%-3.3pp

Returns & leverage

See full
Return on equity32.4%-35.7pp
Debt / equity0.7×-0.2×
Current ratio1.8×0.0×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: Illumina’s 8-K, filed July 30, 2026. Open the filing →

Filed
Jul 30, 2026, 4:07 PM EDT
Accession
0001110803-26-000155

FAQ

What is Illumina's other income, net (note 6)?
Illumina (ILMN) reported other income, net (note 6) of $15M in Q2 2026.
How has Illumina's other income, net (note 6) changed year-over-year?
Illumina's other income, net (note 6) decreased by 86.0% year-over-year, from $107M to $15M.
What is the long-term trend for Illumina's other income, net (note 6)?
Over 3 years (2021 to 2025), Illumina's other income, net (note 6) has grown at a -31.7% compound annual growth rate (CAGR), from $1.07B to $340M.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about Illumina's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude